New MRI dye tested in healthy volunteers to sharpen images
NCT ID NCT05041166
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a special imaging agent called [13C]pyruvate to see how it behaves in healthy organs and tissues during MRI scans. Fifty healthy volunteers aged 18 to 80 will receive an injection of the agent, and researchers will measure image quality. The goal is to improve MRI technology for future disease detection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [13C]pyruvate (a special imaging agent for MRI scans)
- What this could lead to
- If successful, this study could help doctors get clearer MRI images, making it easier to spot diseases in organs and tissues.
- What could go wrong
- This is an early phase 1 study with only 50 healthy volunteers, so results may not apply to people with illnesses. The imaging agent is experimental and its safety in all situations is not yet fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults